Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

ClinicalTrials.gov ID: NCT02599324

Public ClinicalTrials.gov record NCT02599324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b/2 Study of Ibrutinib Combination Therapy in Selected Advanced Gastrointestinal and Genitourinary Tumors

Study identification

NCT ID
NCT02599324
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Pharmacyclics LLC.
Industry
Enrollment
263 participants

Conditions and interventions

Interventions

  • cetuximab Drug
  • docetaxel Drug
  • everolimus Drug
  • ibrutinib Drug
  • paclitaxel Drug
  • pembrolizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2015
Primary completion
Aug 19, 2021
Completion
Aug 19, 2021
Last update posted
Nov 17, 2023

2015 – 2021

United States locations

U.S. sites
44
U.S. states
26
U.S. cities
42
Facility City State ZIP Site status
Clearview Cancer Institute /ID# 1128-0965 Huntsville Alabama 35805
Banner MD Anderson Cancer Center /ID# 1128-0802 Gilbert Arizona 85234
University of Arizona Cancer Center - Tucson /ID# 1128-1546 Tucson Arizona 85724
Alta Bates Comprehensive Cancer Center /ID# 1128-0135 Berkeley California 94704
St Marys Medical Center /ID# 1128-0969 Daly City California 94015
Duplicate_University of California San Diego/ Moores Cancer Center /ID# 1128-0241 La Jolla California 92037-0845
VA Long Beach Healthcare System /ID# 1128-0480 Long Beach California 90822-5201
USC Norris Cancer Center /ID# 1128-0209 Los Angeles California 90033
UC Irvine Medical Center - Chao Family Comprehensive Cancer Center /ID# 1128-0008 Orange California 92868-3201
Salinas Valley Memorial Hosp /ID# 1128-0482 Salinas California 93901
Premiere Oncology, A Medical Corporation /ID# 1128-1085 Santa Monica California 90404
St. Joseph Health /ID# 1128-1462 Santa Rosa California 95403
Gregory Smith, MD (Private Practice) /ID# 1128-0419 St. Helena California 94574
Whittingham Cancer Center at Norwalk Hospital /ID# 1128-0411 Norwalk Connecticut 06856-3852
Georgetown University Hospital /ID# 1128-0824 Washington D.C. District of Columbia 20007
Duplicate_Cancer Specialist of North Florida (CSNF) ( R ) /ID# 1128-1093 Jacksonville Florida 32207
IACT Health-Columbus /ID# 1128-1389 Columbus Georgia 31904-8946
Northshore Kellogg Cancer Center /ID# 1128-0484 Evanston Illinois 60201
Franciscan Health Indianapolis /ID# 1128-1125 Indianapolis Indiana 46237
Horizon Oncology Research Center /ID# 1128-0337 Lafayette Indiana 47905
University of Iowa Hospitals and Clinics /ID# 1128-0766 Iowa City Iowa 52242
The University of Kansas Cancer Center /ID# 1128-0706 Fairway Kansas 66205
East Jefferson General Hospital /ID# 1128-1084 Metairie Louisiana 70006
Duplicate_Tufts Medical Center /ID# 1128-0016 Boston Massachusetts 02111-1552
Barbara Ann Karmanos Cancer In /ID# 1128-0130 Detroit Michigan 48201
Henry Ford Hospital /ID# 1128-0195 Detroit Michigan 48202
Central Care Cancer Center /ID# 1128-1596 Bolivar Missouri 65613
Capital Region Medical Center /ID# 1128-1412 Jefferson City Missouri 65102
Nebraska Methodist Hospital /ID# 1128-0229 Omaha Nebraska 68114
New Jersey Center for Cancer Research /ID# 1128-0493 Brick New Jersey 08724
Duplicate_New Mexico Cancer Care Alliance /ID# 1128-0938 Albuquerque New Mexico 87106
San Juan Oncology Associates /ID# 1128-1020 Farmington New Mexico 87401
Memorial Sloan Kettering Cancer Center-Koch Center /ID# 1128-0091 New York New York 10065-6007
Wake Forest Univ HS /ID# 1128-0975 Winston-Salem North Carolina 27157
Oregon Health & Science University /ID# 1128-0251 Portland Oregon 97239-3011
Penn State Hershey Medical Ctr /ID# 1128-0220 Hershey Pennsylvania 17033-2360
Abramson Cancer Center of the Univ. of Pennsylvania /ID# 1128-0402 Philadelphia Pennsylvania 19104
Vanderbilt Infectious Disease Clinic /ID# 1128-0024 Nashville Tennessee 37232
The University of Texas Medical Branch (UTMB) - Cancer Center - Galves /ID# 1128-0974 Galveston Texas 77555-0565
Duplicate_Scott & White Mem Hosp & Clin /ID# 1128-0046 Temple Texas 76508
Duplicate_Virginia Cancer Specialists - Fairfax Office /ID# 1128-0972 Fairfax Virginia 22031
Virginia Mason Medical Center /ID# 1128-0005 Seattle Washington 98101
University of Washington /ID# 1128-1382 Seattle Washington 98109
Confluence Health /ID# 1128-0894 Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02599324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2023 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02599324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →